about
Large Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation DynamicsModeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacyViral and latent reservoir persistence in HIV-1-infected patients on therapyHIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirsModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesModelling HIV immune response and validation with clinical data.Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.A Bayesian Approach in Differential Equation Dynamic Models Incorporating Clinical Factors and Covariates.Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease.Impact of latently infected cells on strain archiving within HIV hosts.Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.Apoptosis in virus infection dynamics models.In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 monthsHuman systems immunology: hypothesis-based modeling and unbiased data-driven approaches.A perspective on modelling hepatitis C virus infection.Outcome Prediction in Mathematical Models of Immune Response to Infection.Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance.EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.Statistical methods for HIV dynamic studies in AIDS clinical trials.Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibilityTransient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.Modeling complex decay profiles of hepatitis B virus during antiviral therapy.Hepatitis C Viral Kinetics in Special PopulationsAsymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.Modeling HIV persistence, the latent reservoir, and viral blips.Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection.Viral Decay Dynamics and Mathematical Modeling of Treatment Response: Evidence of Lower in vivo Fitness of HIV-1 Subtype CSpatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.Computational study to determine when to initiate and alternate therapy in HIV infection.Anti-proliferative therapy for HIV cure: a compound interest approach.An HIV model with age-structured latently infected cells.Multi-scale immunoepidemiological modeling of within-host and between-host HIV dynamics: systematic review of mathematical modelsGlobal stability of HIV infection of CD4+ T cells and macrophages with CTL immune response and distributed delays.A comprehensive hepatitis C viral kinetic model explaining cure.Free terminal time optimal control problem of an HIV model based on a conjugate gradient method.Periodic multidrug therapy in a within-host virus model.Viral dynamics model with CTL immune response incorporating antiretroviral therapy.Latently infected cell activation: a way to reduce the size of the HIV reservoir?
P2860
Q27339956-8353990D-C7EB-4655-8B48-A7C0E8928BC8Q27485474-2D2F26A8-D153-4707-9059-D529241B5986Q28469057-EE419F8A-87BF-467D-8FBD-4C9F4EB2906AQ28477500-F307D56D-7F64-4B2D-9FE9-48B5CD7D21D1Q28484046-D01D23A2-BE3D-4E2D-9B7B-58137F4A2B0AQ33460449-7ED4D379-B4B3-43A8-BEC6-3B3296B14D9DQ33510903-32046120-5BB2-4E4E-B74E-8DC3D370F0BFQ33824478-3A5CEE34-77D5-420B-9AE2-2105223F20E6Q33870943-B4A45D25-4782-4CA6-9929-788B90BD8B64Q33906899-514240E6-4115-4ABE-BB9D-C19F0C0A59C8Q34331710-ECA124DD-9163-4B40-8D48-F537ADD583A7Q34344290-244E4165-9F1D-4DCB-ABF6-8C4F353A4F5BQ34455550-7E20F799-2C93-40A3-BC52-4679DAE0A2BFQ34465982-8DCC6314-AFC9-4E7E-9FAF-B7606F75D42EQ34572554-5C6CF85A-FB9B-46A1-AFB8-293579B4CFDFQ34759489-137E9C63-64DE-45A9-99D6-952C9FB50C96Q35750046-84BCFB73-FE14-4931-87AD-AB78D32907C8Q35819184-C2AE5B0B-1A0A-4840-98DF-856B63562CD7Q35914310-E8321A5E-0182-4B72-9DC1-C6F34C27068CQ35921909-2A25FB41-BF4F-485C-9101-FE16AB2B4DECQ36088015-BA3AA2D2-651E-41B2-B4C0-81510ABC9E89Q36492224-FF09E05A-7A72-4A70-B401-F202E277E56AQ36977630-1C1D9E75-FE78-47DA-95CE-91E6FDFB585CQ37017548-F51D6B49-F0AB-4AF7-9FA9-315A732111F9Q37060801-D6687F92-AAA3-4AD0-BC33-EC5F84E752CAQ37133236-9F19505A-65D0-4761-80BD-F48ECF1B9F52Q37365718-6F8BEE20-00C7-403E-85EF-C49FEA512680Q37511462-71892136-401E-44D9-B98C-14D9CBFAF7E0Q37519818-D7BBB319-BBD8-4A89-82D1-1D16CDE12B22Q37621893-8891DC4F-D8B2-4D75-BED4-CFFBFF2F81E2Q40030171-B458DD58-8C66-4421-BCEF-F9DFDBD62ED4Q40150493-2DE037F5-C7AD-4FE9-8A06-12BD46418932Q40638814-25985335-30AC-4850-BFF5-C82A3F5DF8C5Q41925810-4078EBA4-56CD-417F-A538-F95830E5D74CQ42247521-C072733A-DE5B-4171-BD81-701E79009FE8Q42997057-F48F46FE-907F-4D1B-8106-16A911DF4A5BQ44619079-6A84F249-86E6-4F58-A21C-214563F5D5AFQ45364338-8235A844-F662-4B53-91EE-C7FFBF6E4AB0Q46518762-AB7F30B0-DDCC-4614-9F2B-70D45776A68FQ47311740-33C09EB4-ADF6-4EF0-A706-8C3AD19E50EB
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
HIV-1 infection and low steady state viral loads.
@en
HIV-1 infection and low steady state viral loads.
@nl
type
label
HIV-1 infection and low steady state viral loads.
@en
HIV-1 infection and low steady state viral loads.
@nl
prefLabel
HIV-1 infection and low steady state viral loads.
@en
HIV-1 infection and low steady state viral loads.
@nl
P356
P1476
HIV-1 infection and low steady state viral loads.
@en
P2093
Duncan S Callaway
P2888
P356
10.1006/BULM.2001.0266
P577
2002-01-01T00:00:00Z
P6179
1051633192